Nestlé Is Developing New Products for Weight Loss Drug Users as GLP-1 Drugs Change How People Eat
Deborah Oladapo
Tue, August 18, 2026 at 6:06 PM GMT+5:30
6 min read
- NESN.SW
-0.03% - WMT
-0.82%
When Ozempic and Wegovy became household names, food companies had an obvious reason to worry. If people were eating less, they might buy fewer snacks, skip frozen meals, and generally put less food in their carts. Investors noticed, too. Nestlé shares dipped in late 2023 after Walmart’s U.S. CEO said the retailer had seen a slight decrease in food purchases among customers taking appetite-suppressing GLP-1 medications
Nestlé eventually decided the threat looked more like an opening. Chief technology officer Stefan Palzer says the company is now using artificial intelligence and nutritional science to develop products specifically around the changing needs of people on GLP-1 medicines, turning smaller appetites and new nutritional priorities into a consumer category of their own
Some of those products are already on shelves
The more interesting question is whether they solve problems whole foods cannot, or package familiar nutrients for a fast-growing market willing to pay attention
The Scare That Set Up a New Product Line
It took roughly a year for investor anxiety to become a real frozen-food product
In May 2024, Nestlé announced Vital Pursuit, a frozen-food line designed as a companion for people using GLP-1 medicines or managing their weight. The initial range included 12 products, including whole grain and protein pasta bowls, sandwich melts, and pizzas. The meals were positioned as high in protein and fiber, with portions intended to suit smaller appetites.CNBC reported prices at $4.99 or less
Nestlé also made a notable marketing choice. Nestlé deliberately kept “GLP-1” off the packaging, planning instead to make the connection through social media
What Palzer described this August is much bigger than one freezer-aisle brand. Nestlé is building a broader portfolio strategy around protein, collagen, ingredient patents, and AI-assisted research across multiple brands and markets
Muscle Loss, Ozempic Face, and What Nestlé Says It Can Do
Nestlé’s product strategy is organized around what rapid weight loss does to the body, not just to the appetite
“We are well positioned with the portfolio,” Palzer told Reuters. “It’s ahuge opportunity for our company.”
One of the company’s biggest areas of interest is lean muscle. “A big part of weight loss is that people lose lean muscle mass,” Palzer added. Nestlé says it has identified a combination of two micronutrients, which it has not publicly named, that couldsupport muscle recovery during rapid weight reduction
